Vincristine Systematic (IUPAC) name methyl (1R,9R,10S,11R,12R,19R)- 11-(acetyloxy) Clinical data AHFS/Drugs.com MedlinePlus Pregnancy cat. D(AU) D(US) Legal status ℞ Prescription only Routes Exclusively intravenous Pharmacokinetic data Bioavailability n/a Protein binding ~75% Metabolism Hepatic Half-life 19 to 155 hours Excretion Mostly biliary, 10% in urine Identifiers CAS number ATC code L01 PubChem DrugBank ChemSpider UNII KEGG ChEBI ChEMBL Chemical data Formula C46H56N4O10 Mol. mass 824.958 g/mol SMILES & (what is this?)
Vincristine (brand name, Oncovin), formally known as leurocristine, sometimes abbreviated "VCR", is a vinca alkaloid from the Catharanthus roseus (Madagascar periwinkle), formerly Vinca rosea and hence its name. It is a mitotic inhibitor, and is used in cancer chemotherapy.
Tubulin is a structural protein that polymerizes to microtubules. The cell cytoskeleton and mitotic spindle, among other things, are made of microtubules. Vincristine binds to tubulin dimers, inhibiting assembly of microtubule structures. Disruption of the microtubules arrests mitosis in metaphase. Therefore, the vinca alkaloids affect all rapidly dividing cell types including cancer cells, but also those of intestinal epithelium and bone marrow.
Vincristine is delivered via intravenous infusion for use in various types of chemotherapy regimens. Its main uses are in non-Hodgkin's lymphoma as part of the chemotherapy regimen CHOP, Hodgkin's lymphoma as part of MOPP, COPP, BEACOPP, or the less popular Stanford V chemotherapy regimen, in acute lymphoblastic leukemia, and in treatment for nephroblastoma (Wilms tumor, a kidney tumor most common in young children). It is also used to induce remission in ALL with Dexamethasone and L-Asparaginase. Vincristine is occasionally used as an immunosuppressant, for example, in treating thrombotic thrombocytopenic purpura (TTP) or chronic idiopathic thrombocytopenic purpura (ITP). It is used in combination with prednisone to treat childhood leukemia.
Peripheral neuropathy can be severe, and hence a reason to avoid, reduce, or stop the use of vincristine. One of the first symptoms of peripheral neuropathy is foot drop: A person with a family history of foot drop and/or Charcot-Marie-Tooth disease (CMT) may benefit from genetic testing for CMT before taking vincristine.
Accidental injection of vinca alkaloids into the spinal canal (intrathecal administration) is highly dangerous, with a mortality rate approaching 100 percent. The medical literature documents cases of ascending paralysis due to massive encephalopathy and spinal nerve demyelination, accompanied by intractable pain, almost uniformly leading to death; a handful of survivors were left with devastating neurological damage with no hope of recovery. Rescue treatments consist of washout of the cerebrospinal fluid and administration of protective medications. A significant series of inadvertent intrathecal vincristine administration occurred in China in 2007 when batches of cytarabine and methotrexate (both often used intrathecally) manufactured by the company Shanghai Hualian were found to be contaminated with vincristine.
Having been used as a folk remedy for centuries, studies in the 1950s revealed that C. roseus contained 70 alkaloids, many of which are biologically active. While initial studies for its use in diabetes mellitus were disappointing, the discovery that it caused myelosuppression (decreased activity of the bone marrow) led to its study in mice with leukemia, whose lifespan was prolonged by the use of a vinca preparation. Treatment of the ground plant with Skelly-B defatting agent and an acid benzene extract led to a fraction termed "fraction A". This fraction was further treated with aluminium oxide, chromatography, trichloromethane, benz-dichloromethane, and separation by pH to yield vincristine.
Vincristine was approved by the United States Food and Drug Administration (FDA) in July 1963 as Oncovin. The drug was initially discovered by a team led by Dr. J.G. Armstrong; it was then marketed by Eli Lilly and Company.
Three generic drug makers supply vincristine in the United States - APP, Mayne, and Sicor (Teva).
- Rosy Periwinkle
- ^ Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD (1996). "Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A". Cancer 77 (7): 1356–62. doi:10.1002/(SICI)1097-0142(19960401)77:7<1356::AID-CNCR20>3.0.CO;2-#. PMID 8608515.
- ^ Qweider M, Gilsbach JM, Rohde V (2007). "Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report". J Neurosurg Spine 6 (3): 280–3. doi:10.3171/spi.2007.6.3.280. PMID 17355029.
- ^ Tainted Drugs Tied to Maker of Abortion Pill, Jake Hooker and Walt Bogdanich, New York Times, January 31, 2008
- ^ Johnson IS, Armstrong JG, Gorman M, Burnett JP (1 September 1963). "The vinca alkaloids: a new class of oncolytic agents". Cancer Res 23 (8 Part 1): 1390–427. PMID 14070392. http://cancerres.aacrjournals.org/cgi/reprint/23/8_Part_1/1390.
- Vincristine chemotherapy
- Vincristine and vinblastine
- Description and Natural History of the Periwinkle
- The Boger Route to (-)-Vindoline
- U.S. National Library of Medicine: Drug Information Portal - Vincristine
Intracellular chemotherapeutic agents/antineoplastic agents (L01) SPs/MIs
(M phase)Block microtubule assemblyBlock microtubule disassembly
inhibitorIIICrosslinking of DNA
(CCNS)Aziridines: Carboquone • ThioTEPA • Triaziquone • Triethylenemelamine
Photosensitizers/PDT OtherOther/ungroupedAmsacrine • Trabectedin • retinoids (Alitretinoin, Tretinoin) • Arsenic trioxide • asparagine depleters (Asparaginase/Pegaspargase) • Celecoxib • Demecolcine • Elesclomol • Elsamitrucin • Etoglucid • Lonidamine • HAMLET (human alpha-lactalbumin made lethal to tumor cells) • Lucanthone • Mitoguazone • Mitotane • Oblimersen • Omacetaxine mepesuccinate • mTOR inhibitors (Everolimus, Temsirolimus)
tumr, epon, para
Wikimedia Foundation. 2010.
Look at other dictionaries:
Vincristine — structure Général Synonymes 22 oxovincaleucoblastine No CA … Wikipédia en Français
vincristine — ☆ vincristine [vin kris′tēn, vin kris′tin ] n. [< L vinca, periwinkle (prob. < vincere: see VINCULUM) + crista, crest + INE3] an alkaloid, C46H56N4O10·H2SO4, obtained from the leaves of a periwinkle ( Vinca rosea) and used as a drug in the… … English World dictionary
vincristine — vincristine. См. винкристин. (Источник: «Англо русский толковый словарь генетических терминов». Арефьев В.А., Лисовенко Л.А., Москва: Изд во ВНИРО, 1995 г.) … Молекулярная биология и генетика. Толковый словарь.
vincristine — ● vincristine nom féminin Alcaloïde de la pervenche d Amérique (Vinca rosea) utilisé, à l état de sulfate notamment, dans le traitement des leucémies aiguës … Encyclopédie Universelle
vincristine — noun Etymology: vinca + Latin crista crest + English 2 ine more at crest Date: circa 1962 an alkaloid C46H56N4O10 from the rosy periwinkle used especially in the form of its sulfate to treat some human neoplastic diseases (as acute leukemia) … New Collegiate Dictionary
vincristine — Cytotoxic alkaloid that binds to tubulin and interferes with microtubule assembly. See vinblastine, a related compound … Dictionary of molecular biology
vincristine — /vin kris teen/, n. Pharm. an alkaloid, C46H56N4O10, derived from the periwinkle, Vinca rosea, used in the management of leukemias and lymphomas. [1960 65; < NL Vin(ca) a periwinkle genus + L crist(a) CREST + INE2] * * * … Universalium
vincristine — noun A particular drug used in chemotherapy … Wiktionary
vincristine — vin·cris·tine ( )vin kris .tēn n an alkaloid that is obtained from the rosy periwinkle and that is used esp. in the form of its sulfate C46H56N4O10·H2SO4 to treat some human neoplastic diseases (as acute leukemia) called also leurocristine see… … Medical dictionary
vincristine — [vɪn krɪsti:n] noun Medicine a compound obtained from a species of periwinkle (plant) and used to treat acute leukaemia and other cancers. Origin 1960s: from mod. L. Vinca (see vinca) + a second element perh. based on crista + ine4 … English new terms dictionary